ISIS-2: 10-year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. - Baigent,C.; Collins,R.; Appleby,P.; Parish,S.; Sleight,P.; Peto,R,. (BJM, 1998)